These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 23558472

  • 1. Detection of minimal residual disease in lung cancer.
    Chudacek J, Bohanes T, Klein J, Benedikova A, Srovnal J, Szkorupa M, Skalicky P, Skarda J, Hajduch M, Neoral C.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Jun; 158(2):189-93. PubMed ID: 23558472
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Diagnostic utility of LunX mRNA in peripheral blood and pleural fluid in patients with primary non-small cell lung cancer.
    Cheng M, Chen Y, Yu X, Tian Z, Wei H.
    BMC Cancer; 2008 May 31; 8():156. PubMed ID: 18513434
    [Abstract] [Full Text] [Related]

  • 9. Combined detection of CEA, CK-19 and c-met mRNAs in peripheral blood: a highly sensitive panel for potential molecular diagnosis of non-small cell lung cancer.
    Sheu CC, Chang MY, Chang HC, Tsai JR, Lin SR, Chang SJ, Hwang JJ, Huang MS, Chong IW.
    Oncology; 2006 May 31; 70(3):203-11. PubMed ID: 16809939
    [Abstract] [Full Text] [Related]

  • 10. Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.
    Sher YP, Shih JY, Yang PC, Roffler SR, Chu YW, Wu CW, Yu CL, Peck K.
    Clin Cancer Res; 2005 Jan 01; 11(1):173-9. PubMed ID: 15671543
    [Abstract] [Full Text] [Related]

  • 11. [Message RNA expression of LUNX, CK19 and CEA genes in NSCLC with micrometastasis in lymph nodes].
    Wang WB, Cui YG, Yao SY.
    Zhonghua Zhong Liu Za Zhi; 2008 Feb 01; 30(2):121-4. PubMed ID: 18646695
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of different markers in non-small cell lung cancer: prognostic value of clinical staging, tumour cell detection and tumour marker analysis for tumour progression and overall survival.
    Kasimir-Bauer S, Schleucher N, Weber R, Neumann R, Seeber S.
    Oncol Rep; 2003 Feb 01; 10(2):475-82. PubMed ID: 12579292
    [Abstract] [Full Text] [Related]

  • 13. Minimal residual disease monitoring in neuroblastoma patients based on the expression of a set of real-time RT-PCR markers in tumor-initiating cells.
    Hartomo TB, Kozaki A, Hasegawa D, Van Huyen Pham T, Yamamoto N, Saitoh A, Ishida T, Kawasaki K, Kosaka Y, Ohashi H, Yamamoto T, Morikawa S, Hirase S, Kubokawa I, Mori T, Yanai T, Hayakawa A, Takeshima Y, Iijima K, Matsuo M, Nishio H, Nishimura N.
    Oncol Rep; 2013 Apr 01; 29(4):1629-36. PubMed ID: 23417100
    [Abstract] [Full Text] [Related]

  • 14. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
    Koga T, Tokunaga E, Sumiyoshi Y, Oki E, Oda S, Takahashi I, Kakeji Y, Baba H, Maehara Y.
    Hepatogastroenterology; 2008 Apr 01; 55(84):1131-5. PubMed ID: 18705345
    [Abstract] [Full Text] [Related]

  • 15. Quantification of serum MET in non-small-cell lung cancer and its clinical significance.
    Li D, Li F, Wu Y, Zhou D, Chen H.
    Clin Biochem; 2015 Feb 01; 48(3):110-4. PubMed ID: 25489726
    [Abstract] [Full Text] [Related]

  • 16. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer.
    Foa P, Fornier M, Miceli R, Seregni E, Santambrogio L, Nosotti M, Cataldo I, Sala M, Caldiera S, Bombardieri E.
    Anticancer Res; 1999 Feb 01; 19(4C):3613-8. PubMed ID: 10629660
    [Abstract] [Full Text] [Related]

  • 17. Expression and clinical significance of lung-specific X protein mRNA in bronchial brushing specimens from patients with or without lung cancer.
    Lv M, Wu MZ, Zhao YJ, Yang DI, Wang EH, Wu GP.
    Respirology; 2011 Oct 01; 16(7):1076-80. PubMed ID: 21651644
    [Abstract] [Full Text] [Related]

  • 18. [LUNX mRNA in regional lymph nodes of non-small cell lung cancer patients by RT-PCR and its clinical significance].
    Tan S, Cheng Z, Ma Y, Tan S, Yin Z, Hu W, Yu F.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Dec 01; 35(12):1236-41. PubMed ID: 21200090
    [Abstract] [Full Text] [Related]

  • 19. Value of tumour and inflammatory markers in lung cancer.
    Oremek GM, Sauer-Eppel H, Bruzdziak TH.
    Anticancer Res; 2007 Dec 01; 27(4A):1911-5. PubMed ID: 17649794
    [Abstract] [Full Text] [Related]

  • 20. The diagnostic value of circulating stanniocalcin-1 mRNA in non-small cell lung cancer.
    Du YZ, Gu XH, Li L, Gao F.
    J Surg Oncol; 2011 Dec 01; 104(7):836-40. PubMed ID: 21656524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.